LONDON BROKER RATINGS: AstraZeneca cut; Barclays raises Centrica

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

----------

FTSE 100

----------

Deutsche Bank Research cuts AstraZeneca to ’sell’ (hold) - price target 10,500 (11,000) pence

----------

Goldman Sachs raises Entain price target to 1,100 (1,080) pence - ’buy’

----------

Deutsche Bank Research raises Entain price target to 1,158 (1,122) pence - ’buy’

----------

JPMorgan raises Entain price target to 1,150 (1,110) pence - ’neutral’

----------

Barclays raises Centrica to ’overweight’ (equal weight) - price target 210 (180) pence

----------

FTSE 250

----------

Deutsche Bank Research cuts Morgan Advanced price target to 205 (235) pence - ’hold’

----------

SMALL CAP

----------

Berenberg starts Filtronic with ’buy’ - price target 196 pence

----------

Berenberg cuts Sabre Insurance price target to 190 (200) pence - ’buy’

----------

RBC cuts Brooks Macdonald price target to 1,850 (1,900) pence - ’sector perform’

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.